Skip to content

The Effect of Digital Storytelling Intervention Based on Generative AI on Diabetic Kidney Disease Prevention and Control Literacy in Elderly Diabetic Patients

The Effect of Digital Storytelling Intervention Based on Generative AI on Diabetic Kidney Disease Prevention and Control Literacy in Elderly Diabetic Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127333
Enrollment
Unknown
Registered
2026-06-29
Start date
2026-06-30
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly Diabetes

Interventions

Intervention group:Implementing generative AI-based digital storytelling interventions for elderly patients with diabetes mellitus.
Control group:Implementation of routine diabetes health education for elderly patients with diabetes mellitus
Part 1: Observation Group:None
Part 2 :Observation Group:None
Feasibility Study Intervention Group:Implementing generative AI-based digital storytelling interventions for elderly patients with diabetes mellitus.

Sponsors

School of Nursing, Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: Criteria for including participants in the intervention plan consultation: 1. Aged >= 65 years; 2. Diagnosed with diabetes by a hospital at or above the second-level level; 3. No communication barriers and able to express one’s own wishes. Criteria for including participants in the second part of the semi-structured interviews: 1. Aged >= 65 years; 2. Diagnosed with diabetic nephropathy by a hospital at or above the second level, with relatively stable condition and a history of treatment; 3. No communication barriers, able to express own wishes. Part 3: Feasibility study and inclusion criteria for randomized controlled trials: 1. Aged 65 years and above; 2. Diagnosed with diabetes by a hospital at or above the second level, with stable condition; 3. No severe visual or auditory impairments, able to understand and cooperate with the study; 4. Possess a smartphone and be able to use WeChat; 5. Voluntary participation and signing of the informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion criteria for soliciting opinions on the intervention plan: 1. Patients with end-stage diabetic nephropathy; 2. Other organ damages, such as dysfunction of vital organs like the heart, liver, and lungs; 3. Patients in critical conditions and/or at the end-stage of their disease; 4. Patients who are unable to take care of themselves. Criteria for including semi-structured interviews in Part 2: 1. Patients with severe kidney disease caused by other factors, such as obstructive nephropathy or chronic nephritis syndrome, or those with other serious underlying diseases; 2. Patients with damage to other organs, such as dysfunction of vital organs like the heart, liver, and lungs; 3. Patients in critical condition and/or those at the end-stage of their disease; 4. Patients who are unable to take care of themselves. Part 3: Feasibility study and inclusion criteria for randomized controlled trials: 1. Patients diagnosed with diabetic nephropathy or end-stage chronic kidney disease (CKD); 2. Patients with comorbid severe chronic diseases (e.g., malignant tumors, heart failure class III or higher) or acute infectious diseases; 3. Patients exhibiting cognitive impairment (Simple Mental State Questionnaire [SPMSQ] score >= 3), long-term use of medications that may significantly impair cognitive function, history of psychiatric disorders, or impaired communication ability; 4. Participation in other similar intervention studies within the past 3 months; 5. Patients with unstable residence status or plans to relocate during the study period; 6. Patients with limited self-care capacity.

Design outcomes

Primary

MeasureTime frame
Diabetic Kidney Disease Prevention and Control Literacy;

Secondary

MeasureTime frame
Self-Efficacy;Social Support ;Glycated hemoglobin;Fasting blood sugar;Glomerular Filtration Rate;Microalbuminuria in urine;2-hour Postprandial Glucose;

Countries

China

Contacts

Public ContactLin Ting

School of Nursing, Fujian Medical University

fjswbhjx@sina.com+86 136 0953 2214

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026